Fertility Services Market by Procedure (IVF with ICSI, IUI, IVF without ICSI, Surrogacy, and Others), Service (Fresh Non-donor, Frozen Non-donor, Egg & Embryo Banking, Fresh Donor, and Frozen Donor), and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Global Opportunity Analysis and Industry Forecast, 2020–2027

Update Available On-Demand

Fertility Services Market Overview – 2027

The global fertility services market size generated $20,388.61 million in 2019 and is projected to reach $25,709.64 million by 2027, growing at a CAGR of 15.9% from 2020 to 2027.

COVID-19 outbreak had considerable impact across the world. The fertility services market has been negatively impacted by this pandemic. In addition, most fertility clinics across the globe have stopped undertaking new cases of infertility treatment for the next few months, till the condition seems to be under control.

Fertility services are services provided to support the treatment to cure infertility. These services involve techniques such as in vitro fertilization (IVF), artificial insemination, surrogacy, and others, which help in resolving infertility issues among couples, single mothers, and the LGBT community. Infertility can occur in men or women of child-bearing age. In addition, male infertility is identified majorly as a result of low sperm count or decreased motility of sperms, which may be due to hormonal imbalance. Hence, fertility in men and women requires proper functioning of hypothalamus and pituitary gland. Increase in the rate of infertility has occurred majorly due to factors such as increase in the consumption of alcohol and drugs, increased stress level, frequent smoking, obesity, and environmental factors. As per a study by the American Society for Reproductive medicines, in approximately 40% of infertile couples, the male partner is responsible for infertility and among them, approximately 85%–90% are treated with drugs or surgery. This is anticipated to drive the fertility services market growth.

Technological advancements in assisted reproductive technologies, rise in awareness regarding infertility treatment, and growth in number of fertility clinics are expected to drive the fertility services market growth during the forecast period. However, high cost related to the procedure along with stringent regulations pertaining to surrogacy in several countries restrict the growth of the market. Various factors that lead to infertility include problem with sperm or egg production, age, genetic factors, and excessive exposure to some chemicals and toxins. Alcohol consumption, steroid use, surgical removal of one of the testicles due to cancer, and diabetes can also result in low sperm count, thereby leading to infertility problems in men. In women, hormonal disorders, benign growths in uterus, abnormal anatomy of the cervix or uterus, blocked fallopian tubes, stress, chemotherapy, kidney, or sickle cell disease may result in infertility. Furthermore, rise in number of fertility clinics along with growth in awareness about fertility treatments such as sperm/egg donation and in-vitro fertilization escalates the adoption of fertility treatments, thereby propelling the market growth. Moreover, rise in infertility rates is not only due to lifestyle changes but also due to various diseases such as sexually transmitted diseases (STDs) and fertility-related diseases. Hence, the increase in infertility rates in the near future is anticipated to augment the growth of the fertility services market.

Fertility Services Market Segmentation

The fertility services market is classified into procedure, service, end user, and region. By procedure, the market is divided into IVF with intracytoplasmic sperm injection (ICSI), surrogacy, IVF without ICSI, intrauterine insemination (IUI), surrogacy, and others. By service, it is categorized into fresh non-donor, frozen non-donor, egg & embryo banking, fresh donor, and frozen donor. By end user, the market is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, France, Spain, Italy, Russia and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa).

Segment review

By fertility services market analysis, the IVF with ICSI segment accounted for half of the market share in fertility services market in 2019. This segment is expected to exhibit a prominent growth rate, owing to some key factors such as higher success rates associated with ICSI-IVF in case of poor sperm morphology, poor sperm motility, low sperm count, and others. Moreover, rapid increase in infertility rate is one of the major factors that drives the growth of the fertility services market. 

By procedure, the IVF with ICSI segment accounted for the largest market share in 2019. This segment is expected to exhibit a prominent growth rate, attributed to the fact that it has revolutionized male infertility treatment, as it requires smaller number of sperms that are penetrated into the egg with the help of injection technique.

Asia-Pacific presents lucrative opportunities for key players operating in the fertility services market, owing to increase in accessibility and availability of healthcare facilities and rise in healthcare and research expenditure. This region is anticipated to experience rapid market growth due to economic development. Moreover, the fertility services in countries such as India are cheaper as compared to the developed countries such as the U.S., Canada, and others; thereby, fueling the market growth in this region. The growth of the fertility services market is supplemented by surge in adoption of fertility procedures and rise in fertility tourism.

The key players operating in the global fertility services market include Apollo Hospitals Enterprise Ltd., Care Fertility Group, Carolinas Fertility Institute, Genea Limited, The Johns Hopkins Health System Corp, Medicover Group, Monash IVF Group, OvaScience Inc., Progyny Inc., and Xytex Cryo International. Other players in the value chain (not included in the report) include Irvine Scientific, INVO Bioscience, LifeGlobal Group, and IVFtech ApS.

Key Benefits For Stakeholders

• The study provides an in-depth analysis of the fertility services market, and the current trends and future estimations to elucidate the imminent investment pockets.
• It presents a quantitative analysis of the market from 2019 to 2027 to enable stakeholders to capitalize on the prevailing fertility services market opportunities.
• Extensive analysis of the market based on procedures and services assists to understand the trends in the fertility services industry.
• Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the fertility services market.

 Key Market Segments & Key Market Players